Prolidase as a marker of fibrogenesis in idiopathic primary ovarian insufficiency.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To evaluate the serumlevel of prolidase,which isa marker of fibrogenic activity, in women with idiopathic primary ovarian insufficiency (POI).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Eur J Obstet Gynecol Reprod Biol

Title: European journal of obstetrics, gynecology, and reproductive biology

Publisher: Elsevier BV

ISSN (Electronic): 1872-7654

ISSN (Print): 0301-2115

Publication date (Electronic): Feb 2023

Volume: 281

Affiliations

[1 ] Department of Obstetrics and Gynecology, Ankara City Hospital, Ankara, Turkey. Electronic address: emerve04@hacettepe.edu.tr.

[2 ] Department of Obstetrics and Gynecology, Ankara City Hospital, Ankara, Turkey.

[3 ] Department of Biochemistry, Ankara Yıldırım Beyazıt University, Faculty of Medicine, Ankara, Turkey.

Article

Publisher Item ID: S0301-2115(22)00627-3

DOI: 10.1016/j.ejogrb.2022.12.015

PubMed ID: 36521400

SO-VID: 716764d1-8b45-4f4d-8274-deb9a60b2680

History

Keywords: Prolidase,Ovarian failure,Primary ovarian insufficiency,Proline,Hydroxyproline

Data availability:

Keywords: Prolidase, Ovarian failure, Primary ovarian insufficiency, Proline, Hydroxyproline

Comments

Comment on this article

scite_

Cited by 1

Systemic low-dose anti-fibrotic treatment attenuates ovarian aging in the mouse
Authors: Farners Amargant, Carol Vieira, Michele T Pritchard …

See all cited by